Allovir Correlations
ALVR Stock | USD 0.45 0.01 2.17% |
The current 90-days correlation between Allovir and Anebulo Pharmaceuticals is -0.1 (i.e., Good diversification). The correlation of Allovir is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Allovir Correlation With Market
Modest diversification
The correlation between Allovir and DJI is 0.2 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Allovir and DJI in the same portfolio, assuming nothing else is changed.
Allovir |
Moving together with Allovir Stock
0.84 | VALN | Valneva SE ADR | PairCorr |
0.76 | ERNA | Eterna Therapeutics | PairCorr |
0.72 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
0.75 | PFE | Pfizer Inc Fiscal Year End 4th of February 2025 | PairCorr |
0.78 | GNFT | Genfit | PairCorr |
0.79 | MRVI | Maravai Lifesciences | PairCorr |
0.62 | RANI | Rani Therapeutics | PairCorr |
0.86 | ABBV | AbbVie Inc | PairCorr |
0.63 | ABOS | Acumen Pharmaceuticals | PairCorr |
0.83 | AMGN | Amgen Inc | PairCorr |
0.74 | APGE | Apogee Therapeutics, | PairCorr |
0.65 | AQST | Aquestive Therapeutics | PairCorr |
0.69 | ARDX | Ardelyx | PairCorr |
0.81 | AVDL | Avadel Pharmaceuticals | PairCorr |
Moving against Allovir Stock
0.78 | DYAI | Dyadic International | PairCorr |
0.67 | ESPR | Esperion Therapeutics | PairCorr |
0.63 | BMY | Bristol Myers Squibb | PairCorr |
0.45 | GILD | Gilead Sciences Sell-off Trend | PairCorr |
0.36 | DNA | Ginkgo Bioworks Holdings | PairCorr |
0.67 | MNMD | Mind Medicine | PairCorr |
0.51 | ABCL | Abcellera Biologics | PairCorr |
0.6 | TARS | Tarsus Pharmaceuticals | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Allovir Stock performing well and Allovir Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Allovir's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ANEB | 4.69 | (0.34) | 0.00 | (0.35) | 0.00 | 7.64 | 76.00 | |||
MLYS | 2.84 | (0.09) | 0.00 | 0.05 | 3.45 | 7.51 | 20.98 | |||
ANTX | 2.50 | 0.47 | 0.16 | 0.54 | 2.03 | 6.34 | 28.89 | |||
AVTE | 2.38 | 0.43 | 0.17 | 0.62 | 1.99 | 5.58 | 19.11 | |||
ADAG | 4.73 | (0.33) | 0.00 | 16.30 | 0.00 | 8.13 | 41.45 | |||
FIXX | 2.82 | 0.09 | 0.01 | 0.23 | 3.52 | 5.77 | 19.43 | |||
STOK | 2.64 | (0.29) | 0.00 | (0.07) | 0.00 | 5.57 | 21.35 | |||
BCEL | 3.90 | 0.31 | 0.02 | (0.16) | 5.00 | 7.53 | 23.80 | |||
BDTX | 3.44 | (1.35) | 0.00 | (0.56) | 0.00 | 5.00 | 18.25 | |||
FDMT | 2.90 | (1.20) | 0.00 | 1.91 | 0.00 | 5.04 | 23.82 |
Allovir Corporate Management
Sonia Choi | Senior Relations | Profile | |
Agustin MD | Advisor | Profile | |
Dana MBA | VP Operations | Profile | |
Ann Leen | Chief Officer | Profile | |
Cintia PharmD | Chief Officer | Profile | |
David Hallal | Executive Board | Profile | |
Jeroen Beek | Consultant | Profile |